3–12 day dispatch window due to updated U.S. documentation requirements • All tariff costs covered
Table of Contents
Choosing the right botulinum toxin option is an important decision for aesthetic professionals who want to provide high-quality treatments for their patients. With so many advanced formulations available today, comparing popular options such as Innotox and Botulax can help qualified healthcare practitioners better understand their differences, benefits, and possible applications.
Both products have gained attention in the aesthetic industry thanks to their modern formulations and reputation among professionals worldwide. But which one is the better choice? The answer depends on several factors, including treatment preferences, clinical experience, patient needs, and the specific characteristics of each product.
Botulinum toxin type A has become one of the most widely used ingredients in aesthetic medicine, especially when it comes to wrinkle reduction. When administered by trained healthcare professionals, it is commonly used to temporarily reduce the appearance of dynamic wrinkles caused by repeated facial movements.
Areas frequently treated with botulinum toxin include:
Although many botulinum toxin products share the same general purpose, each brand may have unique characteristics related to formulation, manufacturing process, storage requirements, and practitioner preference.
Two products that often attract attention from aesthetic specialists are Innotox and Botulax. Both are developed using botulinum toxin type A technology, but they have important differences that professionals should consider before choosing the most suitable option for their practice.
NOTE
Apart from their widespread use in aesthetic medicine, Innotox and Botulax may also have a wide range of potential therapeutic implications, including the management of conditions such as hyperhidrosis and muscle spasticity.
Innotox is a liquid botulinum toxin type A formulation developed by the South Korean company Medytox. Unlike many traditional botulinum toxin options that are supplied as freeze-dried powders requiring reconstitution, Innotox comes in a ready-to-use liquid format.
This feature is one of the main reasons why Innotox has become interesting to many aesthetic professionals. The liquid formula is designed to simplify preparation and provide a consistent product format before treatment.
Some characteristics that make Innotox stand out include:
For many clinics, reducing preparation steps can be an attractive advantage. A simpler preparation process may help professionals save time and maintain an organized treatment environment.
However, as with any aesthetic product, healthcare providers should always follow official product information, professional guidelines, and appropriate clinical protocols when using Innotox.
NOTE
Innotox still requires cold-chain storage at 2–8 °C before and after opening, so it does not remove the need for refrigeration. Its practical advantage lies in skipping reconstitution, not in relaxed storage conditions.
Botulax is another well-known botulinum toxin type A product manufactured in South Korea by Hugel. It has become widely recognized in the global aesthetic market and is used by many qualified professionals who are familiar with traditional toxin formats.
Unlike Innotox, Botulax uses human serum albumin and is typically supplied as a lyophilized (freeze-dried) powder that requires reconstitution before administration. This format is familiar to many practitioners because it follows a preparation style used by numerous botulinum toxin brands.
Botulax is appreciated by professionals for several reasons:
For healthcare professionals who prefer working with a conventional powdered formulation, Botulax may feel more familiar and comfortable. Experience, training, and personal technique often influence a practitioner’s product preference.
NOTE
Innotox shows effects within 2–3 days. While Botulax typically requires 3–7 days for effects to appear.
When comparing Innotox and Botulax, it is important to understand that neither product is automatically the perfect choice for every professional or every patient. The right option depends on individual clinical considerations and the preferences of the practitioner.
One of the biggest distinct differences between the two products is the formulation style. Innotox offers a liquid formulation, while Botulax generally comes as a freeze-dried powder requiring preparation before use. This difference affects how the products are handled in a clinical setting. Additionally, Innotox uses plant-based stabiliser, while Botulax employs human serum albumin. Moreover, Innotox has a broader diffusion profile than Botulax (although both products help in treating common facial wrinkles like forehead lines and crow’s feet).
For practitioners, the choice may depend on factors such as:
Another consideration is the practitioner’s experience. Healthcare professionals often develop preferences based on their own treatment methods and observations over time. Some may appreciate the convenience of a ready-to-use product, while others may prefer the traditional preparation process they already know well.
NOTE
When discussing alternatives to Botox, one of the most frequently asked questions is: “Are Botulax and Innotox FDA-approved?” Neither product is FDA-approved under its original brand name. Innotox has not gone through the FDA approval process required for marketing in the United States. Hugel’s toxin, however, was approved by the FDA in February 2024 under the separate US trade name Letybo, while the Botulax-branded product itself remains outside the US market. Both are Korean botulinum toxins (also known as Korean botulinum neurotoxins type A) approved by South Korea’s Ministry of Food and Drug Safety.
Both Innotox and Botulax are designed to provide consistent results in a temporary improvement in the appearance of wrinkles related to facial muscle activity. They rarely cause any allergic reactions and do a great job when it comes to temporarily blocking nerve signals attached to particular muscles in the treatment zone. However, individual results can vary depending on many factors.
In clinical practice, treatment outcomes may be influenced by:
It is important for professionals to evaluate each patient carefully and create a treatment approach based on their unique needs rather than choosing a product based only on popularity or marketing claims.
Patients often ask about which toxin is “stronger” or “better,” but the most appropriate choice is usually the one that fits the practitioner’s expertise and the patient’s specific goals.
A highly trained injector using a product they understand well can often achieve excellent outcomes through careful assessment and precise technique.
NOTE
Neither Innotox nor Botulax are botulinum toxin formulations that provide permanent results. Therefore, repeated treatments might be required to maintain the outcomes. Their frequency depends on a treatment area, consistent dosing, patient metabolism, and many other factors. On average, Innotox results typically last 3 to 6 months, similar to Botulax results. As clinical outcomes show, fewer injections might be required with time, as a patient’s body adjusts to both products.
Since both treatment options are based on the same active ingredient, do not have too many key differences, and are cost-effective, the decision between Innotox and Botulax should be based on professional judgment, appropriate training, and individual clinical preferences.
Innotox may be a suitable choice for practitioners who:
Botulax, in its turn, may be an effective botulinum toxin type A option for practitioners who:
Ultimately, the “right” choice for the best patient satisfaction is not about selecting a universal winner. Both products have become recognized options in the aesthetic market, and each has features that may appeal to different professionals.
Healthcare providers should always consider official product guidelines, local regulations, patient expectations, and their own clinical experience before incorporating any product into their practice.
NOTE
According to some studies, Innotox shows a lower risk of developing treatment resistance. At the same time, however, Innotox has a more limited global market reach if compared with Botulax.
All in all, Innotox and Botulax are two interesting botulinum toxin options that have earned attention among qualified aesthetic professionals. While Innotox offers the convenience of a liquid formulation and Botulax provides a familiar traditional format, the best choice depends on the practitioner’s experience, workflow preferences, and treatment approach.
Both products discussed above are advantageous options for professionals looking to expand their aesthetic toolkit, and you can safely order them through FillerCloud, a platform designed to help qualified healthcare providers access professional aesthetic products with competitive pricing. Browse across our assortment and buy Botulax, Innotox, or many other botulinum toxin treatments today!
NOTE
Botulax and Innotox for sale are offered exclusively to certified medical specialists since they are the products intended for professional use.
Neither is FDA-approved under its original brand name. Innotox has not entered the US approval process, while Hugel’s toxin reached the US market in February 2024 under the separate trade name Letybo.
Innotox is a ready-to-use liquid stabilised without human serum albumin, so it needs no reconstitution. Botulax is a freeze-dried powder containing human serum albumin that must be reconstituted before use.
Both typically maintain results for about three to six months, depending on the treatment area, dosing, and patient metabolism. Repeat sessions are needed, as neither product produces permanent effects.
Yes. Innotox requires cold-chain storage at 2–8 °C both before and after opening. Its ready-to-use format removes the reconstitution step, but it does not remove the need for refrigerated storage.
You may download the form, complete it and email back to [email protected].
Or fax it at 360.768.3126
